Noninvasive Hemoglobin Monitoring by Spectrophotometry in Blunt Abdominal Trauma Patients for Conservative Management

NCT05171296 | Unknown

• 1 other identifier: FMASU R 177 / 2021
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

We aimed to study the efficacy of Noninvasive Hemoglobin Monitoring by Spectrophotometry in monitoring hemoglobin level in trauma patients for conservative management.

Conditions

Intensive Care Unit

Keywords

massimo

Outcome Measures

Primary Outcomes (1)

• accuracy of hemoglobin measured by the noninvasive device.

  accuracy of hemoglobin measured by the noninvasive hemoglobin test device (Radical-7®; Masimo Corp., Irvine, CA) in comparison with standard CBC that is assayed on Coulter LH 750 Cell Counter (Beckman Coulter Corporation, Florida, USA), using reagents supplied by the company in patients suffering frm blunt abdominal trauma aditted to ICU for observation.

  3 months

Study Arms (1)

abdominal trauma patients

blunt abdominal trauma patients planned for conservation.

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients who will be admitted to Ain Shams university hospital - surgical intensive care unit, after blunt abdominal trauma planned for conservation.

You may qualify if:

• American Society of Anesthesiologists (ASA) physical status I to III, of either sex, 18 -80 years of age, non-sedated non-intubated patients who will be admitted to Ain Shams university hospital - surgical intensive care unit, after blunt abdominal trauma planned for conservation.

You may not qualify if:

• Patients with fever, hypothermia, history of a neurological, psychiatric, dementia or, who are taking psychotropic drugs Patients with unstable hemodynamic status, and unconscious patients.

Sponsors & Collaborators

• Ain Shams University: lead

Study Sites (1)

Ain Shams University hospitals

Cairo, 11591, Egypt

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

complete blood count

Central Study Contacts

Amr hafez, M.D

CONTACT

01225674370; amr_foud@med.asu.edu.eg

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 10, 2021
• First Posted: December 28, 2021
• Study Start: November 22, 2021
• Primary Completion: August 22, 2022
• Study Completion: August 22, 2022
• Last Updated: July 21, 2022

Record last verified: 2022-07

Locations

EG (1)